PL4005606T3 - Kompozycja do podbudzania wzrostu komórek nabłonkowych - Google Patents

Kompozycja do podbudzania wzrostu komórek nabłonkowych

Info

Publication number
PL4005606T3
PL4005606T3 PL21207189.8T PL21207189T PL4005606T3 PL 4005606 T3 PL4005606 T3 PL 4005606T3 PL 21207189 T PL21207189 T PL 21207189T PL 4005606 T3 PL4005606 T3 PL 4005606T3
Authority
PL
Poland
Prior art keywords
cell growth
epithelial cell
growth stimulating
stimulating composition
composition
Prior art date
Application number
PL21207189.8T
Other languages
English (en)
Inventor
Rivelino Montenegro
Thomas Freier
Karsten Henco
Original Assignee
Medoderm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medoderm Gmbh filed Critical Medoderm Gmbh
Publication of PL4005606T3 publication Critical patent/PL4005606T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polymers & Plastics (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL21207189.8T 2009-09-01 2010-09-01 Kompozycja do podbudzania wzrostu komórek nabłonkowych PL4005606T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/006323 WO2011026498A1 (en) 2009-09-01 2009-09-01 Chitosan tissue dressing

Publications (1)

Publication Number Publication Date
PL4005606T3 true PL4005606T3 (pl) 2024-11-04

Family

ID=42115621

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21207189.8T PL4005606T3 (pl) 2009-09-01 2010-09-01 Kompozycja do podbudzania wzrostu komórek nabłonkowych

Country Status (9)

Country Link
US (5) US10207022B2 (pl)
EP (3) EP2473201B1 (pl)
JP (6) JP5752123B2 (pl)
CA (5) CA2771365A1 (pl)
DK (1) DK3572100T3 (pl)
ES (2) ES2980898T3 (pl)
HK (1) HK1246216B (pl)
PL (1) PL4005606T3 (pl)
WO (4) WO2011026498A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3094553B2 (ja) 1991-09-30 2000-10-03 東レ株式会社 タフテッドカーペット及びタフテッドカーペット用基布
CA2771365A1 (en) 2009-09-01 2011-03-10 Medovent Gmbh Chitosan tissue dressing
EP2790623B1 (en) * 2011-12-16 2023-05-31 3M Innovative Properties Company Sealing systems and methods employing a switchable drape
US10940047B2 (en) 2011-12-16 2021-03-09 Kci Licensing, Inc. Sealing systems and methods employing a hybrid switchable drape
DE102012002209A1 (de) * 2012-02-07 2013-08-08 Carl Freudenberg Kg Biodegradierbares Vlies für medizinische Zwecke
US8899277B2 (en) * 2012-08-03 2014-12-02 Shin Era Technology Co., Ltd. Manufacturing method of medical textiles woven from chitosan containing high wet modulus rayon fibre
JP2016537333A (ja) * 2013-11-22 2016-12-01 ソマールション・エルエルシー 臓器組織保存溶液の安定性及び保存可能期間を増加させる溶液
KR102359148B1 (ko) * 2014-01-23 2022-02-08 닛산 가가쿠 가부시키가이샤 배양 배지 조성물
WO2015120085A1 (en) 2014-02-04 2015-08-13 Hemcon Medical Technologies, Inc. Chitosan materials from carbonic acid solution
AU2015269359B2 (en) 2014-06-05 2019-08-15 Kci Licensing, Inc. Dressing with fluid acquisition and distribution characteristics
WO2016164903A1 (en) * 2015-04-10 2016-10-13 Hemcon Medical Technologies, Inc. Bioadhesive chitosan gel for controlling bleeding and for promoting healing with scar reduction without obscuring or interfering with access to a surgical field
WO2018130951A1 (en) * 2017-01-13 2018-07-19 Marteinsson Runar Chitosan-containing formulations and methods of making and using the same
BR112020004843A2 (pt) * 2017-09-12 2020-09-15 Shilpa Medicare Limited aspersão de ácido tranexâmico para artroplastia de joelho
AU2020271339B2 (en) 2019-04-08 2025-12-11 Medoderm Gmbh Liquid composition for influencing the microbiota on a subject's skin comprising chitosan
EP3972562B1 (en) 2019-05-22 2025-09-03 Università Degli Studi Di Torino Medical device comprising a chitosan-based support structure
US20220233656A1 (en) * 2019-05-27 2022-07-28 National University Corporation Tokyo Medical And Dental University Antibacterial composition
EP4228595A1 (en) 2020-10-14 2023-08-23 Medoderm GmbH Liquid composition for use in the prevention or reduction of skin irritation, allergy and/or an infectious disease
CN113813439A (zh) * 2021-11-04 2021-12-21 湖南愈尔美医疗科技有限公司 一种医用酵母重组ⅲ型胶原蛋白敷料的制备方法
US12232944B2 (en) 2022-08-26 2025-02-25 Checkpoint Surgical, Inc. Chitosan tubular member and method of producing

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632754A (en) 1968-02-12 1972-01-04 Lescarden Ltd Use of chitin for promoting wound healing
US4532134A (en) 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JPH0227487B2 (ja) 1982-07-07 1990-06-18 Kokudo Sogo Kensetsu Kk Jibankairyohoho
CA1202904A (en) * 1983-11-21 1986-04-08 Brian G. Sparkes Chitosan based wound dressing materials
JPH0615476B2 (ja) * 1985-05-22 1994-03-02 イハラケミカル工業株式会社 抗感染症剤
JPS61172817A (ja) * 1985-01-25 1986-08-04 Sanyo Chem Ind Ltd 医薬部材組成物
ATE144781T1 (de) * 1986-06-06 1996-11-15 Union Carbide Corp Saure dekristallisierung von hochkristallin chitosan oder teilentacetylierten chitin
US4920158A (en) 1989-10-11 1990-04-24 Medipro Sciences Limited Hydrogel-forming wound dressing or skin coating material
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
FI95207C (fi) * 1992-09-14 1996-01-10 Novasso Oy Haavansuojaside
SE9402531L (sv) 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
US6486140B2 (en) 1994-07-19 2002-11-26 Medicarb Ab Agents, and methods employing them, for the prevention or reduction of tissue adhesion at a wound site
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
JP3511856B2 (ja) 1997-08-04 2004-03-29 コクヨ株式会社 家具の免震装置
GB2329181B (en) * 1997-09-11 2002-03-13 Johnson & Johnson Medical Bioabsorbable Wound Dressing Materials
JP2001055335A (ja) 1999-08-18 2001-02-27 Toshio Sato アレルギー性皮膚疾患治療剤
GB9929472D0 (en) * 1999-12-13 2000-02-09 Btg Int Ltd Polymeric film
GB9929897D0 (en) 1999-12-18 2000-02-09 Slabas Antoni R Improvements in or relating to conjugated fatty acids and related compounds
US6426066B1 (en) * 2000-01-12 2002-07-30 California Pacific Labs, Inc. Use of physiologically balanced, ionized, acidic solution in wound healing
US20020018732A1 (en) * 2000-04-21 2002-02-14 Hung William M. Preserving compositions containing chitosan and processes for making water soluble O-acetylated chitosan and chitosan
US6867287B2 (en) 2000-04-25 2005-03-15 The Procter & Gamble Company Breathable absorbent articles comprising chitosan material
EP1149595A1 (en) * 2000-04-25 2001-10-31 The Procter & Gamble Company Odour control system comprising a cationic polysaccharide and an odour controlling agent
US6960655B2 (en) 2000-04-25 2005-11-01 The Procter & Gamble Company Articles having an odor control system comprising a cationic polysaccharide and an odor controlling agent
EP1149597A1 (en) * 2000-04-25 2001-10-31 The Procter & Gamble Company Breathable absorbent articles comprising chitosan material
GB2369997B (en) * 2000-12-12 2004-08-11 Johnson & Johnson Medical Ltd Dressings for the treatment of exuding wounds
WO2002102276A2 (en) 2001-06-14 2002-12-27 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
JP2003128704A (ja) * 2001-10-24 2003-05-08 Matsumoto Shika Univ キチン・キトサンの低分子化方法及び骨伝導物の製造方法
FR2836044A1 (fr) * 2002-02-15 2003-08-22 Octaris Composition pour la reparation et la cicatrisation cutanee comprenant exclusivement un vrai hydrogel physique de chitosane
JP2004115777A (ja) 2002-09-06 2004-04-15 Ulvac Japan Ltd 抗菌性高分子及びその製造方法、抗菌性高分子被膜及びその作製方法、並びにこの被膜を表面に有する物品
AU2004248971A1 (en) * 2003-06-20 2004-12-29 Johnson & Johnson Medical Limited Antioxidant wound dressing materials
JP2005089372A (ja) * 2003-09-18 2005-04-07 Lion Corp 毛髪化粧料
KR100546793B1 (ko) * 2003-10-27 2006-01-25 주식회사 효성 키토산을 이용한 폼 드레싱재 및 이의 제조방법
JP4124745B2 (ja) * 2004-02-12 2008-07-23 エス・イーケミカル株式会社 キトサン分散液及びその製造方法並びにキトサン膜の製造方法
EP1727569A1 (en) * 2004-03-11 2006-12-06 Medtrade Products Ltd. Compositions of alpha and beta chitosan and methods of preparing them
JP4703283B2 (ja) * 2005-06-20 2011-06-15 星製薬株式会社 創傷被覆材およびその製造方法
JP5160102B2 (ja) * 2006-02-14 2013-03-13 甲陽ケミカル株式会社 非晶質の部分脱アセチル化キチン塩のスポンジ状止血材及びその製造方法
US9028872B2 (en) 2006-03-01 2015-05-12 Fmc Corporation Gelled composite
EP2121026B1 (en) * 2006-12-11 2017-06-28 CHIT2GEL Ltd. Novel injectable chitosan mixtures forming hydrogels
JP5076141B2 (ja) * 2006-12-28 2012-11-21 国立大学法人福井大学 組織再生用組成物及びそれを用いたスキャフォールド
US20100129423A1 (en) * 2007-04-19 2010-05-27 Medovent Gmbh Device made at least partially of n-acetylchitosan with controlled biodissolution
US8541484B2 (en) * 2007-04-24 2013-09-24 The General Hospital Corporation PVA-PAA hydrogels
DE102007038125A1 (de) 2007-08-03 2009-02-05 Aesculap Ag Kombination zum Verkleben von biologischen Geweben
CN104874007A (zh) 2007-08-28 2015-09-02 奥塔哥创新有限公司 手术用水凝胶
US20090117213A1 (en) 2007-11-06 2009-05-07 Clermont Beaulieu Stable solutions having antiviral, antibacterial and hemostatic properties and methods of making thereof
CN102076364B (zh) * 2008-05-02 2014-07-02 普罗维登斯医疗卫生系统-俄勒冈州D/B/A普罗维登斯圣文森特医疗中心 创伤敷裹装置和方法
US20110105709A1 (en) * 2008-07-23 2011-05-05 Sumitomo Seika Chemicals Co., Ltd. Water-soluble acrylic acid salt polymer and gelling base
WO2010021930A1 (en) 2008-08-16 2010-02-25 Synedgen, Inc. Prevention and treatment of mrsa infections with chitosan-derivatives
CN101366969B (zh) * 2008-09-12 2012-07-18 武汉华纳联合药业有限公司 氧化锌作为壳聚糖生物膜的增强剂的用途
FR2937244B1 (fr) * 2008-10-22 2011-11-18 Sofradim Production Implant de remplacement de tendon a base de collagene
CN101507830A (zh) * 2009-03-20 2009-08-19 武汉锐尔生物科技有限公司 一种用于敷料的水胶体及其制备方法
CA2771365A1 (en) * 2009-09-01 2011-03-10 Medovent Gmbh Chitosan tissue dressing

Also Published As

Publication number Publication date
WO2011026869A4 (en) 2011-09-09
US20120209320A1 (en) 2012-08-16
WO2011026869A3 (en) 2011-06-30
EP3117842C0 (en) 2023-11-08
DK3572100T3 (da) 2022-01-31
CA2771365A1 (en) 2011-03-10
US20120252755A1 (en) 2012-10-04
WO2011026498A1 (en) 2011-03-10
CA2771556C (en) 2019-03-12
CA2772800A1 (en) 2011-03-10
US20160279284A1 (en) 2016-09-29
CA2771556A1 (en) 2011-03-10
US10207022B2 (en) 2019-02-19
CA3033304C (en) 2022-08-30
US20120215149A1 (en) 2012-08-23
EP2473200B1 (en) 2016-09-14
CA3033304A1 (en) 2011-03-10
CA2771490C (en) 2016-06-07
EP2473200A2 (en) 2012-07-11
EP3117842A1 (en) 2017-01-18
JP2013503656A (ja) 2013-02-04
US9439998B2 (en) 2016-09-13
WO2011026614A2 (en) 2011-03-10
EP3117842B1 (en) 2023-11-08
CA2772800C (en) 2017-03-21
EP2473201B1 (en) 2016-08-10
WO2011026870A1 (en) 2011-03-10
CA2771490A1 (en) 2011-03-10
JP2015186582A (ja) 2015-10-29
US9814800B2 (en) 2017-11-14
JP2015157816A (ja) 2015-09-03
JP6069394B2 (ja) 2017-02-01
HK1246216B (en) 2020-04-09
JP5782442B2 (ja) 2015-09-24
ES2908609T3 (es) 2022-05-03
JP2013503818A (ja) 2013-02-04
EP2473201A1 (en) 2012-07-11
JP5752123B2 (ja) 2015-07-22
US20120232032A1 (en) 2012-09-13
WO2011026870A4 (en) 2011-05-19
JP2013503654A (ja) 2013-02-04
WO2011026869A2 (en) 2011-03-10
ES2980898T3 (es) 2024-10-03
JP6250591B2 (ja) 2017-12-20
JP2017213376A (ja) 2017-12-07
WO2011026614A3 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
IL216624A0 (en) Fucosylation-deficient cells
IL215393A0 (en) Therapy for promoting cell growth
GB0908613D0 (en) T Cell Reseptors
DK3572100T3 (da) Sammensætning til stimulering af epitelcellevækst
IL214660A0 (en) Agricultural composition
GB0904263D0 (en) Electrolyte composition
GB0920775D0 (en) Cells
GB0816577D0 (en) Growth factor
IL199639A0 (en) Improvement of cell growth
PL3572100T3 (pl) Kompozycja do pobudzania wzrostu komorek nabłonkowych
GB0915268D0 (en) Cell culture
GB0922428D0 (en) Cell culture
GB0900845D0 (en) Reprogramming cells
GB0808076D0 (en) Cell growth inhibition composition
GB0908223D0 (en) Cells
GB0901675D0 (en) Cells
HUE052153T2 (hu) Fukoziláció-deficiens sejtek
GB0810781D0 (en) Feeder cells
AU2009903367A0 (en) Mombai girdle
GB0912287D0 (en) Cells, compositions and methods
GB0920035D0 (en) Cell
GB0906303D0 (en) Culture
GB0906308D0 (en) Culture
GB0906301D0 (en) Culture
GB0906306D0 (en) Culture